We are currently wimessing an "epidemic" of meta-analyses and overviews in the scientific literature. This is a relatively new phenomenon and this article addresses some of the important issues raised by their increasing use. In particular the differing applications and limitations of metaanalysis are discussed, with a review of the analytic methods used and the problems and biases encountered. October 1990 Why use meta-analysis? Traditionally, when seeking advice in controversial or novel areas, clinicians and scientists have relied heavily on "informed" editorials or narrative reviews. There is now good evidence to suggest that these traditional methods are subject to bias and inaccuracy.3 Reviewers using traditional methods are less likely to detect a small but significant effect or difference compared with reviewers using formal statistical techniques.4 In controversial topics, such as reviews of the uses of new procedures, the enthusiasm for the procedure may be associated more with the specialty of the reviewer than with the results of the trials.5 As most current medical reviews do not use scientific methods to assess and present data, different reviewers often reach different conclusions based on the same data.6 For these reasons some formal statistical process of review should replace the informal approach. Meta-analysis can be used to resolve uncertainty when reports, editorials or reviews disagree.
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Although the randomised controlled clinical trial is now accepted as the gold standard method of assessing therapeutic regimes, individual trials may produce false positive or negative conclusions. Small numbers and the consequent lack ofpower ofany individual study is usually the main problem area. 7 The problem of small numbers is particularly relevant when dealing with subgroup analysis, for which very often the randomised controlled trial was not designed. Combining 13 which showed the efficacy of post-discharge treatment by combining the results of over 60 small studies. It also produced a useful framework for future studies. Another meta-analysis has concluded that steriods are of benefit in meningitis in children, 14 another that H2 antagonists are ofonly minor benefit in the treatment of gastrointestinal haemorrhage, and only in gastric ulcers. '5 Although the vast majority of meta-analyses concern the assessment of therapies in randomised controlled trials, a few studies have addressed contentious aetiological issues such as the quantification of the effect of passive smoking on the risk of lung cancer,'6 alcohol in breast cancer,"7 the oral contraceptive pill in rheumatoid arthritis,'8 and leukaemia in refinery workers. '9 Study design in meta-analysis With the proliferation of meta-analyses, it has become apparent that their design, methods and publication should be conducted in a rigorous scientific manner, akin to that currently expected of randomised controlled trials. This is to allow critical appraisal of each individual meta-analysis in terms of its methodology and therefore the validity of its conclusions. A meta-analysis should be a research study in its own right. Specific a priori aims should be set out and a working protocol established.
Having defined the aims of the study, a thorough search of relevant publications needs to be performed. independently assessed "quality", derived from a large number of predetermined "quality" criteria.26 The pooled estimate can then be adjusted accordingly, or else the quality* score used to exclude studies. A simpler method for trials has been proposed which concentrates on three areas of potential bias, namely treatment allocation by randomisation, inclusion of all randomised individuals in analysis, and the blindness of the outcome assessments.27 Quality assessments have also been used in epidemiological studies.'7 28 The major problem with quality weighting is that it must remain arbitrary and to an extent subjective. A single choice of weights is difficult to justify; for example, is it worse to have poor blinding or poor randomisation? Moreover the procedure goes against the general purpose of meta-analysis, that is to obtain an objective summary of the available evidence. Because of the time and resources needed to undertake full quality assessment, its routine use cannot be recommended unless its true worth becomes established. Theoretically publication bias could be prevented or markedly reduced if researchers reported all studies undertaken and journals accepted papers based on methods rather than results. These ideals may be a long way off, and perhaps the most practical step would be the extension ofclinical trial registers into other fields and disciplines.40 41 Statistical methods The first step in meta-analysis should simply be to display the estimated treatment effects, together with their confidence intervals, for each study. Although the smallest and least informative studies have wide confidence intervals that tend to dominate the diagram visually, the careful inspection of such displays often prompts most of the conclusions that will emerge from a numerical analysis. There are two general philosophies for producing a combined estimate of effect and its confidence interval, the so called "fixed effect" and "random effects" methods. They differ in their assumptions about the true underlying treatment effects in the different studies.
In the fixed effect method, all the studies are assumed to be estimating the same underlying treatment effect. In this situation, the most precise overall average of observed treatment effects is obtained by weighting each individual treatment effect inversely according to its variance. 42 This can be applied directly, for example, to log odds ratios as summaries of each trial's observed treatment effect. Logistic regression is also sometimes used, i7 and is in fact equivalent to such an analysis. The MantelHaenszel method weights the odds ratios (not their logarithms) approximately inversely according to their variances43; in many instances the choice between odds ratios and log odds ratios is unimportant.
Peto's "observed minus expected" (O-E) method13 44 is equivalent to the Mantel-Haenszel test. For each study, the "observed" number of events in the treated or exposed group is compared with that "expected" if the treatment or exposure had no effect. Often the sources of any heterogeneity are intangible. If so, it may be difficult to justify a single combined estimate for all the studies. One formal approach is the random effects method47 in which both a between study variance and the within study variances are taken into account in deriving the weighting given to each study. However, the method cannot be regarded as a panacea for heterogeneity. The between study variance, estimated from the x2 statistic for heterogeneity, is itself imprecise and, being often strongly dependent on the inclusion or exclusion of small studies, is susceptible to the effects of publication bias. Also, the representation of differences between studies by a single variance is conceptually inadequate.
The numerical methods used in meta-analysis are therefore most reasonably based on the following sequence. A fixed effect method may be used initially, but it should be followed by an assessment of heterogeneity. The random effects method may then be useful in assessing the robustness of the initial conclusions to failure in the assumption of no heterogeneity. If the conclusions from each method agree, there is naturally greater confidence in them; if not, that the interpretation is problematic should be made explicit.
Conclusions
Meta-analysis is here to stay. Epidemiologists, statisticians, and clinicians should all be aware of the uses and limitations of the technique. A useful by product of the growing use of this form of analysis has been the greater awareness of the need for consistency in the way clinical trials and epidemiological studies are presented, so that the results from these studies can be combined. This will undoubtedly have the effect of improving the quality of methodology, assessment, and presentation of clinical research and the availability of study data for future meta-analysis. Despite the potential problems and pitfalls we have outlined, meta-analysis should play a leading role in the review of scientific issues. This necessitates a fuller understanding of metaanalysis as a routine analytical tool, but also a wider appreciation of the issues involved.
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